Results

Total Results: over 10,000 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections
  3. psnet.ahrq.gov/primer/coronavirus-disease-2019-covid-19-and-safety-older-adults
    April 10, 2024 - reopen including: Criteria, based on an individual state’s level of community transmission, to determine phase … Reopening nursing homes–phase 1–how does it begin? CMS Compliance Group, Inc . May 21, 2020.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
    April 01, 2011 - Takeda has completed a phase 1, randomized, open-label, 2 period, crossover study to evaluate the effect … release (MR) - The objective of the study was to assess the safety of dexlansoprazole MR from the phase … Pediatric patients - Dexlansoprazole is not FDA approved for use in patients less than 18 years of age.1A phase … dexlansoprazole in adolescents 12-17 years of age with symptomatic GERD has been completed.8 A second phase
  7. hcup-us.ahrq.gov/datainnovations/clinicaldata/WAFinalReport042309.jsp
    July 01, 2016 - DOH feels that this project has set a good foundation for either taking this activity into a pilot phase … Given the current budget crisis, AHRQ may be able to kick start the next development phase by providing
  8. Wafinalreport042309 (pdf file)

    hcup-us.ahrq.gov/datainnovations/clinicaldata/WAFinalReport042309.pdf
    April 23, 2009 - DOH feels that this project has set a good foundation for either taking this activity into a pilot phase … Given the current budget crisis, AHRQ may be able to kick start the next development phase by providing
  9. www.ahrq.gov/sites/default/files/2024-01/schnipper-report.pdf
    January 01, 2024 - was the long delay between sites signing up for the study (i.e., during the grant application 18 phase
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/z8AVsCHJEZUBSJtdSx424H
    May 23, 2019 - episodic$ or alcoholic intoxication).mp. 4 1 or 2 or 3 5 limit 4 to (clinical trial or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or controlled … episodic$ or alcoholic intoxication).mp. 4 1 or 2 or 3 5 limit 4 to (clinical trial or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or controlled
  13. ecareplan.ahrq.gov/collaborate/download/temp/downloadM2Uu4142558.zip?contentType=application/zip
    May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned Phase … with: Single value term bindings New or existing value sets Cardinalities of attribute and elements Phase … apps AND how to recruit and troubleshoot the apps for patients 44 User Acceptance Testing Approach Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II Phase II: Chaperoned patient and provider testing of both apps Extend the model above with real patient
  14. ecareplan.ahrq.gov/collaborate/download/temp/downloadJhlcp223213.zip?contentType=application/zip
    May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned Phase … with: Single value term bindings New or existing value sets Cardinalities of attribute and elements Phase … apps AND how to recruit and troubleshoot the apps for patients 44 User Acceptance Testing Approach Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II Phase II: Chaperoned patient and provider testing of both apps Extend the model above with real patient
  15. ecareplan.ahrq.gov/collaborate/download/temp/downloadAZ2BG222954.zip?contentType=application/zip
    May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned Phase … with: Single value term bindings New or existing value sets Cardinalities of attribute and elements Phase … apps AND how to recruit and troubleshoot the apps for patients 44 User Acceptance Testing Approach Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II Phase II: Chaperoned patient and provider testing of both apps Extend the model above with real patient
  16. ecareplan.ahrq.gov/collaborate/download/temp/downloadVatm6143310.zip?contentType=application/zip
    May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned Phase … with: Single value term bindings New or existing value sets Cardinalities of attribute and elements Phase … apps AND how to recruit and troubleshoot the apps for patients 44 User Acceptance Testing Approach Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II Phase II: Chaperoned patient and provider testing of both apps Extend the model above with real patient
  17. cmext.ahrq.gov/confluence/download/export/downloadb6ZH1015505.zip?contentType=application/zip
    September 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned Phase … with: Single value term bindings New or existing value sets Cardinalities of attribute and elements Phase … apps AND how to recruit and troubleshoot the apps for patients 44 User Acceptance Testing Approach Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II Phase II: Chaperoned patient and provider testing of both apps Extend the model above with real patient
  18. digital.ahrq.gov/sites/default/files/docs/page/do_medicaid_schip_needsassessment2008_final.pdf
    July 01, 2009 - health IT initiatives Number of agencies Agencies* Two health IT initiatives, both in implementation phase … 2 MO, NM Two health IT initiatives, both in planning phase 5 AZ, MN, NH, NV, OH Two health IT … other being planned 9 DE, FL, GA, ME, MT, NC, OR, PA, TX One health IT initiative in implementation phase … 6 AL-Medicaid, CA, IA, MI, PR, WI One health IT initiative in planning phase 6 AL-CHIP, CO, MD,
  19. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/stpra/stpra.pdf
    March 01, 2012 - Once the site visits had been completed, we created a series of tables for each surgical phase (i.e. … The operative phase demonstrated the most consistency across study sites with respect to the surgical … communications tended to break down such as between the ASCs and physicians’ offices during the preoperative phase … The use of simulation exercises can be beneficial in this phase of the process.
  20. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/stpra/stpra.pdf
    March 01, 2012 - Once the site visits had been completed, we created a series of tables for each surgical phase (i.e. … The operative phase demonstrated the most consistency across study sites with respect to the surgical … communications tended to break down such as between the ASCs and physicians’ offices during the preoperative phase … The use of simulation exercises can be beneficial in this phase of the process.